Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Recent & Breaking News (NDAQ:ECYT)

Endocyte Stockholders Approve Merger Agreement with Novartis AG

GlobeNewswire December 20, 2018

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Endocyte, Inc. In The U.S. District Court For The Southern District Of New York

PR Newswire November 16, 2018

Recent Analysis Shows Audentes Therapeutics, Endocyte, Bluerock Residential Growth REIT, Air Products and Chemicals, BWX Technologies, and Modine Manufacturing Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire November 9, 2018

Endocyte Provides Third Quarter 2018 Financial Results and Operational Update

GlobeNewswire November 7, 2018

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Endocyte, Inc. - ECYT

PR Newswire November 1, 2018

The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default

Benzinga.com  October 26, 2018

The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut

Benzinga.com  October 19, 2018

Mid-Day Market Update: Down Down Over 300 Points; Endocyte Shares Spike Higher

Benzinga.com  October 18, 2018

Novartis To Buy Endocyte In $2.1B Deal

Benzinga.com  October 18, 2018

The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs

Benzinga.com  October 18, 2018

Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share

Benzinga.com  October 18, 2018

Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion

GlobeNewswire October 18, 2018

New Research Coverage Highlights Endocyte, Power Integrations, Caterpillar, PROS, Ingevity, and SunCoke Energy — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire October 10, 2018

Endocyte becomes first Purdue startup to reach $1.5B in value

GlobeNewswire October 3, 2018

Endocyte to Present at Two Investor Conferences on October 2nd

GlobeNewswire September 27, 2018

Endocyte Announces Closing of Public Offering of Common Stock

GlobeNewswire September 14, 2018

Endocyte Announces Pricing of Public Offering of Common Stock

GlobeNewswire September 11, 2018

Endocyte Announces $175.0 Million Proposed Public Offering of Common Stock

GlobeNewswire September 10, 2018

Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)

GlobeNewswire September 10, 2018

Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference

GlobeNewswire August 29, 2018